Zusammenfassung
Die häufigsten obstruktiven Atemwegserkrankungen sind das Asthma bronchiale und die chronische obstrukte Bronchitis.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Literatur
Adam D, Ferlinz R, Frei R, Geisler L, Knothe H, Lode H, Shah P (1992) Antibakterielle Therapie bei infektiösen Bronchialerkrankungen. Med Monatsschr Pharm 15: 100–105
Appleton S, Smith B, Veale A, Bara A (2001) Long-acting beta 2-agonists for chronic obstructive pulmonary disease (Cochrane Review). In: The Cochrane Library, Issue 1, 2001, Oxford.
Asthma im Kindesalter (1992) Arzneimittelbrief 28:97–99
Barnes PG (1995) Beta-adrenergic receptors and their regulation. Am J Respir Crit Care Med 152:838–860
Barnes PJ (1994) Cytokines as mediators of chronic asthma. Am J Respir Crit Care Med 150:542–549
Barnes PJ, Adcock I (1992) Anti-inflammatory actions of steroids: Molecular mechanisms. Trends Pharmacol Sci 14:436–441
Barnes PJ, Pauwels R (1994) Theophylline in the management of asthma: time for reappraisal. Eur Respir J 7:579–591
Barnes PJ (1998) Chronic obstructive pulmonary disease: new opportunities for drug development. Trends Pharmacol Sci 19:415–423
Barr RG, Rowe BH, Camargo Jr CA (2001) Methyl-xanthines for exacerbations of chronic obstructive pulmonary disease (Cochrane Review). In: The Cochrane Library, Issue 1, 2001, Oxford.
Boulet LP (1994) Long- versus short-acting ß2-agonists. Implications for drug therapy. Drugs 47:207–222
Brogden RN, Faulds D (1991) Salmeterol xinafoate. A review of its pharmacological properties and therapeutic potential in reversible obstructive airway disease. Drugs 42:895–912
Chung KF, Barnes PJ (1988) PAF-antagonists. Their potential role in asthma. Drugs 35:93–103
Coleman RA, Johnson M, Nials AT, Vardey CJ (1996) Exosites: their current status, and their relevance to the action of long-acting ß2-adrenoceptor agonists. Trends in Pharmacol Sci 17:324–330
Collis MG, Hourani DMP (1993) Adenosine receptor subtypes. Trends Pharmacol Sci 14:360–366
Drazen JM, Israel E, O’Byrne PM (1999) Treatment of asthma with drugs modifying the leukotriene pathway. N Engl J Med 340:197–206
Editorial (1999) Behandlung der stabilen chronisch obstruktiven Lungenerkrankung. Arznei-telegramm 9:91–94
Giembycz MA (1996) Phosphodiesterase 4 and tolerance to ß2-adrenoceptor agonists. Trends in Pharmacol Sci 17:331–336
Gonzalez JP, Brogden RN (1987) Nedocromil sodium. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of reversible obstructive airways disease. Drugs 34:560–577
Halliday HL (1996) Natural vs Synthetic surfactants in neonatal respiratory distress syndrome. Drugs 51:226–237
Hofmann F, Ludwig A, Pfeiffer A, Raeburn D, Giembycz MA (eds) (1994) Cyclic GMP and the control of airways smooth muscle tone. In: Airways smooth muscle biochemical control of contraction and relaxation. Birkhäuser, Basel, pp 253–269
Hanania NA, Chapman KR, Sturtridge WC et al (1995) Doserelated decrease in bone density among asthmatic patients treated with inhaled corticosteroids. J Allergy Clin Immunol 96:571–579
Howarth PH, Bradding P, Montefort S et al. (1994) Mucosal inflammation and asthma. Am J Respir Crit Care Med 150:518–522
Jarvis B, Markham A (2000) Montelukast: a review of its therapeutic potential in persistent asthma. Drugs 59:891–928
Knight DA, Stewart GA, Thompson PJ (1994) The respiratory epithelium and airway smooth muscle homeostasis: its relevance to asthma. Clin Exp Allergy 24:698–706
Kroegel C, Herzog V, Knöchel B, et al (1996) 5-Lipoxigenase-Inhibitoren und Leukotrien-Rezeptorantagonisten. Arzneimittelther. 14:299–309
Linden J (1994) Cloned adenosine A3-receptors. Pharmacological properties, species differences and receptor function. Trends Pharmacol Sci 15:298–306
Lipworth BJ (1999) Modern drug treatment of chronic asthma. Brit Med J 318:380–383
Lipworth BJ (1999) Leukotriene-receptor antagonists. Lancet 353:57–62
Magnussen H (1993) Der schwere und lebensbedrohliche Asthmaanfall. Internist 36:779–784
McFadden ER, Hejal R (1995) Asthma. Lancet 345:1215–1220
McGill KA, Busse WW (1996) Zileuton. Lancet 348:519–524
Milgrom H, Fick RB Jr, Su JQ et al. (1999) Treatment of allergic asthma with monoclonal anti-IgE antibody, rhuMAB-E25 Study Group. N Engl J Med 341:1966–1973
Morley j (1994) K+ channel openers and suppresion of airway hyperreactivity. Trends Pharmacol Sci 15:463–468
Pauwels RA (1989) New aspects of the therapeutic potential of theophyllin in asthma. J Allergy Clin Immunol 83:548–553
Pauwels RA, Lofdahl CG, Postma DS et al. (1997) Effect of inhaled formoterol and budenoside on exacerbations of asthma. Formoterol and Corticosteroid Establishing Therapy (FACET) International Study Group. N Engl J Med 337:1405–1411
Persson CGA (1987) The pharmacology of antiasthmatic xanthines and the role of adenosine. Asthma Rev 1:61–93
Poole PJ, Black PN (2001) Mucolytic agents for chronic bronchitis (Cochrane Review). In: The Cochrane Library, Issue 1, 2001, Oxford.
Rhoden KJ (1988) Inhibition of cholinergic neurotransmission in human airways by ß-2-adrenoceptors. J Appl Physiol 65:700–705
Richardson P (1987) Oral N-acetylcysteine: how does it act? Eur J Respir Dis 70:71–72
Schmidt M, Martin E (1994) Asthma und Antiasthmatika. Wissenschaftliche Verlagsgesellschaft, Stuttgart
Sorkness CA (2001) Leukotriene receptor antagonists in the treatment of asthma. Pharmacotherapy 21:34S–37S
Spitzer WO, Suissa S, Ernst P et al. (1992) The use of ß-ago-nists and the risk of death and near death from asthma. N Engl J Med 326:501–506
Thesen R (1993) Colfosceril zur Surfactantsubstitution. Pharmazeut Ztg 138:1793–1798
Torphy TJ (1994) ß-adrenoceptors, cAMP and airway smooth muscle relaxation: challenges to the dogma. Trends Pharmacol Sci 15:370–374
Weinberger M, Hendeles L (1996) Theophylline in Asthma. NEJM 334:1380–1388
Wettengel R, Berdel D, Hofmann D et al (1998) Asthmatherapie bei Kindern und Erwachsenen. Empfehlungen der Deutschen Atemwegsliga in der Deutschen Gesellschaft für Pneumologie. Med Klinik 93:639–650
Wettengel R (1999) Zum Kataraktrisiko durch inhalative Kortikoide. Pneumologie 53:409–410
Wood-Baker R, Walters EH, Gibson P (2001) Corticosteroids for acute exacerbations of chronic obstructive pulmonary disease (Cochrane Review). In: The Cochrane Library, Issue 1, 2001, Oxford.
Woolcock AJ (1990) ß-Agonists and asthma mortality. Drugs 40:653–656
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Hackenthal, E. (2002). Pharmaka mit Wirkung auf den Respirationstrakt. In: Oberdisse, E., Hackenthal, E., Kuschinsky, K. (eds) Pharmakologie und Toxikologie. Springer-Lehrbuch. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56314-0_31
Download citation
DOI: https://doi.org/10.1007/978-3-642-56314-0_31
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-62634-0
Online ISBN: 978-3-642-56314-0
eBook Packages: Springer Book Archive